Welcome to our dedicated page for Manulife Finl SEC filings (Ticker: MFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Manulife Financial Corporation (MFC) regulatory filings as a foreign issuer with the U.S. Securities and Exchange Commission. Manulife is an international financial services and direct life insurance company headquartered in Toronto, Canada, with shares listed on multiple exchanges. As a foreign private issuer, it files annual reports on Form 40‑F and furnishes interim and event‑driven information on Form 6‑K.
Through these SEC filings, investors can review a range of documents that Manulife incorporates by reference into its registration statements on Forms F‑3 and F‑10. Examples referenced in recent Form 6‑K submissions include news releases on quarterly results and dividend declarations, the company’s Third Quarter and Second Quarter Reports to Shareholders (containing management’s discussion and analysis and unaudited interim consolidated financial statements), its Code of Business Conduct and Ethics, underwriting agreements for securities offerings, and supplemental indentures related to issued debt.
Filings also document capital markets transactions, such as the pricing of U.S. public offerings of senior notes, and link to rating‑related disclosures and other material information. These materials help readers understand Manulife’s financial reporting, capital structure, and governance framework, including how the company uses senior unsecured debt, subordinated debentures, preferred shares, and limited recourse capital notes as part of its financing.
On Stock Titan, Manulife’s SEC filings are updated as new Form 6‑K and related documents are released through EDGAR. AI‑powered tools can assist users by summarizing long filings, highlighting key sections in quarterly reports, and making it easier to locate items such as dividend announcements, offering documents, and governance materials embedded within Manulife’s cross‑referenced filings.
Manulife Financial Corporation has received Toronto Stock Exchange approval for a normal course issuer bid to buy back for cancellation up to 42 million common shares, representing about 2.5% of its issued and outstanding shares. As at February 10, 2026, it had 1,676,751,543 common shares outstanding.
Purchases may occur from February 24, 2026 to February 23, 2027 through the TSX, New York Stock Exchange, and other Canadian and U.S. trading systems, with a daily TSX limit of 1,483,481 shares based on average trading volume of 5,933,925 shares. All repurchased shares will be cancelled as part of Manulife’s capital management strategy.
Manulife may also use private agreements and derivative-based programs, and has implemented an automatic share purchase plan so its broker can continue buying shares even during blackout periods, subject to applicable Canadian, U.S., and other securities and insurance regulations.
Manulife-affiliated investment managers report a significant institutional stake in Xperi Inc. Manulife Investment Management (US) LLC beneficially owns 2,522,844 shares of Xperi common stock, representing 5.44% of the 46,335,385 shares outstanding as of October 28, 2025. Manulife Investment Management Limited holds an additional 8,911 shares, or 0.02%. Through its indirect, wholly owned subsidiaries, Manulife Financial Corporation may be deemed to beneficially own these same shares. The ownership information is reported as of the event date December 31, 2025.
Manulife-affiliated investment managers report a significant ownership stake in Citizens Community Bancorp Inc. Manulife Investment Management (US) LLC holds 488,509 shares of Citizens Community common stock, representing 5.06% of the class. Manulife Investment Management Limited holds 1,984 shares, or 0.02%.
The filing states that Manulife Financial Corporation, as the indirect parent of these subsidiaries, may be deemed to beneficially own the same shares. The percentages are based on 9,659,745 Citizens Community common shares outstanding as of November 4, 2025, as reported in the issuer’s Form 10-Q.
Manulife Financial Corporation plans a new Normal Course Issuer Bid that would allow it to repurchase for cancellation up to 42 million common shares, about 2.5% of its issued and outstanding stock, subject to Toronto Stock Exchange approval.
As of January 31, 2026, Manulife had 1,676,743,043 common shares outstanding. The bid may run for up to one year once accepted and permits purchases on the TSX, NYSE, alternative trading systems, and via private agreements or derivative-based programs, all within the 42 million-share cap. Canada’s federal insurance regulator has approved the bid, which follows completion of a prior 51.5 million-share buyback at a volume weighted average price of $44.28.
Manulife Financial Corporation has scheduled its annual shareholder meeting for May 14, 2026. Shareholders of record on March 16, 2026 will be entitled to receive notice and vote at the meeting.
The notice confirms that common shares are the securities entitled to notice and vote, and that Manulife will use notice-and-access for both registered and beneficial owners, with the issuer paying for sending proxy materials to objecting beneficial owners via intermediaries.
Manulife Financial Corporation filed an independent auditor’s report covering its consolidated financial statements for the years ended December 31, 2025 and 2024. The auditors conclude that the statements present fairly the company’s financial position and performance in accordance with IFRS.
The report highlights key audit matters, including the valuation of $541 billion of insurance contract liabilities and $95.3 billion of Level 3 invested assets that rely on complex models and non-observable inputs. It also focuses on IFRS 9 hedge accounting, where Manulife recorded changes in value of hedged assets of $338 million and hedged liabilities of $1,180 million in 2025.
The auditors describe extensive testing of controls, models, and assumptions, and note they have nothing to report regarding inconsistencies in accompanying management discussion and other information reviewed to date.
Manulife Financial Corporation reported full-year and fourth-quarter 2025 results highlighted by record core earnings of $7.5 billion, up 3% on a constant exchange rate basis, and core EPS of $4.21, up 8%. Net income attributed to shareholders was $5.6 billion, up 2%, while reported EPS reached $3.07, up 6%.
Core ROE was 16.5% for 2025 and 17.1% in 4Q25, with the LICAT ratio at 136%. Insurance growth was strong: 2025 APE sales rose 14%, new business increased 28% and NBV grew 18%. Asia and Global segments drove double‑digit core earnings growth, while the U.S. segment saw lower core earnings.
Manulife returned $5.4 billion to shareholders in 2025, including repurchasing 54.4 million common shares, or 3.1% of shares outstanding, for $2.4 billion and paying dividends. The Board approved a 10.2% increase in the quarterly common dividend to $0.485 per share and announced a new NCIB permitting repurchase of up to approximately 2.5% of outstanding common shares, subject to TSX approval.
Manulife Financial Corporation has filed its 2025 audited annual financial statements for the year ended December 31, 2025 and the related MD&A with securities regulators, including the Canadian Securities Administrators and the U.S. Securities and Exchange Commission on Form 40-F. The documents are available on Manulife’s website, and shareholders can request hard copies free of charge. Manulife describes itself as a leading international financial services provider, operating as Manulife in Canada, Asia and Europe and primarily as John Hancock in the United States. At the end of 2024, it had more than 37,000 employees, over 109,000 agents and served over 36 million customers worldwide.
Manulife Financial Corporation has filed its Form 40-F annual report for the fiscal year ended December 31, 2025. The filing incorporates by reference the company’s consolidated financial statements, management’s discussion and analysis, and annual information form, all covering the 2025 fiscal year.
The report confirms that Ernst & Young LLP, based in Toronto, serves as independent auditor and has provided an attestation on internal control over financial reporting. As of December 31, 2025, Manulife had 1,677,180,680 common shares outstanding, along with multiple series of preferred shares.
The document outlines Manulife’s governance framework, including a largely independent board, four fully independent board committees, and a company-wide Code of Business Conduct and Ethics with no waivers granted in 2025. It also references disclosures on off-balance sheet arrangements, contractual obligations, and audit committee practices available in the accompanying exhibits.
Manulife Financial Corporation submitted a Form 6-K as a foreign private issuer for December 2025. The filing primarily furnishes a Fifth Supplemental Indenture dated December 11, 2025 between Manulife and The Bank of New York Mellon, which is included as Exhibit 99.1 and incorporated by reference into Manulife’s Form F-10 registration statement.